Fred Hassan is the former CEO of three global pharmaceutical companies and is now a board member of four publicly traded healthcare companies. Contact: fred.hassan@caretgroup.com.
Why organizations seeking resilience should emulate biopharmaceutical companies that embrace cutting-edge technologies and risk-taking to address unmet patient needs
Ivey Businesss School